Eyal Leibovitz
- Endocrinology, Diabetes and Metabolism top 5%
- Surgery
- Cardiology and Cardiovascular Medicine top 10%
- Physiology
- Immunology
- Co-authors
- Dov GavishErnesto L. SchiffrinMona BoazReuven ZimlichmanJulio WainsteinI ShapiraA RubinsteinMickey Scheinowitz
- Topics
- Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers)Lipoproteins and Cardiovascular Health (10 papers)Diabetes Management and Research (10 papers)
- Cited by
- Endocrinology, Diabetes and MetabolismGeriatrics and GerontologyCardiology and Cardiovascular Medicine
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
Eyal Leibovitz
69 papers receiving 968 citations
Peers
Comparison fields: 5 of 101
- Endocrinology, Diabetes and Metabolism 319
- Surgery 270
- Cardiology and Cardiovascular Medicine 233
- Physiology 179
- Immunology 148
Countries citing papers authored by Eyal Leibovitz
This map shows the geographic impact of Eyal Leibovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Leibovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Leibovitz more than expected).
Fields of papers citing papers by Eyal Leibovitz
This network shows the impact of papers produced by Eyal Leibovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Leibovitz. The network helps show where Eyal Leibovitz may publish in the future.
Co-authorship network of co-authors of Eyal Leibovitz
This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Leibovitz. A scholar is included among the top collaborators of Eyal Leibovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Leibovitz. Eyal Leibovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 11 | |
| 5 | 11 | |
| 6 | 37 | |
| 7 | 48 | |
| 8 | 7 | |
| 9 | 4 | |
| 10 | 20 | |
| 11 | 101 | |
| 12 | 1 | |
| 13 | 8 | |
| 14 | 40 | |
| 15 | Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study. | 2 |
| 16 | 23 | |
| 17 | 11 | |
| 18 | 1 | |
| 19 | 6 | |
| 20 | 29 |
About Eyal Leibovitz
Eyal Leibovitz is a scholar working on Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Immunology and Allergy, having authored 73 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers), Lipoproteins and Cardiovascular Health (10 papers) and Diabetes Management and Research (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (319 citations), Geriatrics and Gerontology (59 citations) and Cardiology and Cardiovascular Medicine (233 citations). Eyal Leibovitz has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Dov Gavish, Ernesto L. Schiffrin, Mona Boaz, Reuven Zimlichman, Julio Wainstein, I Shapira, A Rubinstein, Mickey Scheinowitz, David Hasdai and Talin Ebrahimian. Their work appears in journals such as Annals of the New York Academy of Sciences, The American Journal of Medicine and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.